Liberation Bioindustries, Inc. — Form D
Liberation Bioindustries, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-10. The offering totals $101.7M, of which $60.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-12-10
- Form: D
- Accession: 0001952448-25-000004
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $101.7M
- Amount sold: $60.2M
- Remaining: $41.5M
- Investors: 7
- Date of first sale: 2025-11-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-566313
Issuer
- Name: Liberation Bioindustries, Inc.
- CIK: 0001952448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 14 Wall Street, NEW YORK, NY, 10005
- Phone: 917-539-8620
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Philip Boigner | Director | New York, NY |
| Steven Finn | Director | SAN DIEGO, CA |
| Babar Khan | Director | SAN DIEGO, CA |
| James Mellon | Director | New York, NY |
| Mark Warner | Director | New York, NY |
| Etan Bendheim | Executive Officer | New York, NY |
| Mark Warner | Executive Officer | New York, NY |
| Etan Bendheim | Director | New York, NY |
| Anthony Chow | Director | Douglas, Y8 |
Other filings by this issuer (2)
More